Veracyte (VCYT) Announces New General Manager Structure
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/25/2026
- Nasdaq lags on angst over AI spending ahead of earnings reports
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil falls on report China pushing for end US-Iran war
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- FDA approves Tylenol with Naproxen as first OTC combo pain reliever
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Nasdaq lags on angst over AI spending ahead of earnings reports
Veracyte Announces New General Manager Structure to Advance Global Expansion
November 17, 2020 8:30 AM ESTJohn Hanna appointed GM, endocrinology, breast cancer and lymphoma;
Morten Frost to join company as GM, pulmonology
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte (Nasdaq: VCYT) today announced a new general manager-based structure to advance the companys growing roster of genomic tests and its global expansion.... More
